ALZN
ALZN
NASDAQ · Biotechnology

Alzamend Neuro Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.16
-0.04 (-3.33%)
As of Jun 29, 10:42 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,255.2% upside
Low Target $24.59
Average Target $38.92
High Target $51.00
Current Price $1.16
Current
$1.16
Target
$38.92
$24.59 $38.92 avg $51.00
Scenario Analysis
Bear Case
$24.59
2,019.8%
Low target
Base Case
$38.92
+3,255.2%
Avg target
Bull Case
$51.00
+4,296.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.60
-67.8% from high
52-Week Low
$0.84
+38.1% from low
Target vs 52W High
$38.92
+981.1% vs high
Next Earnings Report
Jul 20, 2026 · Before Market Open
19d
until earnings
EPS Est: $-0.68
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%